Laetrile/Amygdalin (PDQ®)–Health Professional Version
SECTIONS
- Overview
- General Information
- History
- Laboratory/Animal/Preclinical Studies
- Human/Clinical Studies
- Adverse Effects
- Summary of the Evidence for Laetrile/Amygdalin
- Changes to This Summary (07/14/2016)
- About This PDQ Summary
- View All Sections
Changes to This Summary (07/14/2016)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
This section was extensively revised.
This summary is written and maintained by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
.png)
No hay comentarios:
Publicar un comentario